Introduction

BMRT® (Bill Medical Regenerative Therapy) is a high intensity therapy based on a vast number of human donors antibodies. Every therapy contains antibodies harvested from 10000 to 30000 healthy blood donors depending on number of infusions. This makes trillions of new antibodies against a gigantic number of diseases and physical states and is highly active in immune modulation.

​

BMRT® may be used in addition to stem cell therapy and other therapies (complementary therapy). Production is extremely complicated and individually performed for every single patient. Based on almost three decades of research and clinical experience, we have been able to develop a list of indications in which ultra high dosage antibody therapy has proven its value:

​

Indications (Scientific results: see below)

• Longevity Therapy and Health Improvement

• Burn Out Therapy and Regenerative Therapy

• Immune Therapy*

• Alzheimer Disease

• Anti-Inflammatory Therapy and Chronic Pain Relief

• Support of IVF (artificial insemination)

• Supportive/Preventive Cancer Therapy

​

*Immune Therapy for treatment of Autoimmune/Neurological Diseases: e.g. Psoriasis, Thyroiditis, (Rheumatoid) Arthritis, Multiple Sclerosis, Bowel Inflammatory Diseases, Kawamoto Syndrome, Guillain-Barré-Syndrome, Borreliosis, Post-Lyme-Syndrome and many more antibody modulated diseases.

​

Treatment principle of BMRT® Ultra High Dosage Antibody Therapy:

• Extracted blood donor antibodies with individual laboratory set up of polyclonal antibodies

• Immune Modulation: The vast amount of new and individually adjusted antibodies attacks all antigens that cause disorders

• Antibody Direct Reaction

• Antibody Cross Reaction

• Regulation of imbalance of antibodies

• Reduction of build-up of toxins in blood

• Balance of hormones

​

Clinical examination

In a long-term clinical study starting in 2005 and continuing to the present day, patients treated with BMRT® therapy are examined before and after treatment. In addition to clinical parameters, a visual analogue scale (VAS) is used.

The patients were assigned to different indication groups. As many patients appear in several groups at the same time due to their multimorbidity, the total number of patients and the percentage distribution deviates from the sum of the groups.

​

Randomized Double-Blind Studies

In addition randomized double-blind studies were carried out. These studies ALL had to be discontinued for ethical reasons after it was established that BMRT® therapy was clearly superior to placebo administration based on the interim data analysis.

​

Below you find a list of indications for the use of BMRT® that is scientifically investigated. As research on immunomodulated diseases is far from complete, the range of indications is constantly being expanded.

 

If you have any questions about other diseases and health conditions that are not listed here, you can contact us at any time.